Triggering Receptor Expressed on Myeloid Cell 1

Critical Care Clinics

Volumn 27, Issue 2, 2011, Pages 265-279

  Barraud, Damien ^a   Gibot, Sébastien ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

Infection; Innate immunity; Sepsis; Soluble TREM 1; TREM 1

Indexed keywords

ANTIBIOTIC AGENT; CELL SURFACE RECEPTOR; IMMUNOMODULATING AGENT; PEPTIDE; PROTEIN LP17; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; UNCLASSIFIED DRUG;

BACTERIAL INFECTION; DISEASE MARKER; HUMAN; IMMUNOMODULATION; INFECTION; INFLAMMATION; INNATE IMMUNITY; MACROPHAGE; NEOPLASM; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEPSIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION;

ANIMALS; ARTHRITIS; BIOLOGICAL MARKERS; CRITICAL ILLNESS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MONOCYTES; NEUTROPHILS; PANCREATITIS; PERITONITIS; PLEURAL EFFUSION; PNEUMONIA; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, IMMUNOLOGIC; SEPSIS; URINARY TRACT INFECTIONS; VASCULITIS;

EID: 79953020890     PISSN: 07490704     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccc.2010.12.006     Document Type: Review

References (68)

1. Tang B.M., Eslick G.D., Craig J.C., et al. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007, 7(3):210-217.
2. Ford J.W., McVicar D.W. TREM and TREM-like receptors in inflammation and disease. Curr Opin Immunol 2009, 21(1):38-46.
3. Colonna M., Facchetti F. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses. J Infect Dis 2003, 187(Suppl 2):S397-S401.
4. Bouchon A., Facchetti F., Weigand M.A., et al. TREM-1 amplifies inflammation and is a crucial mediator of septic shock. Nature 2001, 410(6832):1103-1107.
5. Radsak M.P., Salih H.R., Rammensee H.G., et al. Triggering receptor expressed on myeloid cells-1 in neutrophil inflammatory responses: differential regulation of activation and survival. J Immunol 2004, 172(8):4956-4963.
6. Bouchon A., Dietrich J., Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes. J Immunol 2000, 164(10):4991-4995.
7. Bleharski J.R., Kiessler V., Buonsanti C., et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol 2003, 170(7):3812-3818.
8. Gibot S., Kolopp-Sarda M.N., Bene M.C., et al. A soluble form of the triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J Exp Med 2004, 200(11):1419-1426.
9. Lanier L.L., Bakker A.B. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function. Immunol Today 2000, 21(12):611-614.
10. Gomez-Pina V., Soares-Schanoski A., Rodriguez-Rojas A., et al. Metalloproteinases shed TREM-1 ectodomain from lipopolysaccharide-stimulated human monocytes. J Immunol 2007, 179(6):4065-4073.
11. Wong-Baeza I., Gonzalez-Roldan N., Ferat-Osorio E., et al. Triggering receptor expressed on myeloid cells (TREM-1) is regulated post-transcriptionally and its ligand is present in the sera of some septic patients. Clin Exp Immunol 2006, 145(3):448-455.
12. Haselmayer P., Grosse-Hovest L., von Landenberg P., et al. TREM-1 ligand expression on platelets enhances neutrophil activation. Blood 2007, 110(3):1029-1035.
13. Hamerman J.A., Tchao N.K., Lowell C.A., et al. Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12. Nat Immunol 2005, 6(6):579-586.
14. Hamerman J.A., Ogasawara K., Lanier L.L. Cutting edge: toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J Immunol 2004, 172(4):2001-2005.
15. Gibot S., Kolopp-Sarda M.N., Bene M.C., et al. Plasma level of a triggering receptor expressed on myeloid cells-1: its diagnostic accuracy in patients with suspected sepsis. Ann Intern Med 2004, 141(1):9-15.
16. Latour-Perez J., Alcala-Lopez A., Garcia-Garcia M.A., et al. Diagnostic accuracy of sTREM-1 to identify infection in critically ill patients with systemic inflammatory response syndrome. Clin Biochem 2010, 43(9):720-724.
17. Barati M., Bashar F.R., Shahrami R., et al. Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of sepsis. J Crit Care 2010, 25(2):362. e1-6.
18. Kofoed K., Andersen O., Kronborg G., et al. Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study. Crit Care 2007, 11(2):R38.
19. Chen H.L., Hung C.H., Tseng H.I., et al. Soluble form of triggering receptor expressed on myeloid cells-1 (sTREM-1) as a diagnostic marker of serious bacterial infection in febrile infants less than three months of age. Jpn J Infect Dis 2008, 61(1):31-35.
20. Sarafidis K., Soubasi-Griva V., Piretzi K., et al. Diagnostic utility of elevated serum soluble triggering receptor expressed on myeloid cells (sTREM)-1 in infected neonates. Intensive Care Med 2010, 36(5):864-868.
21. How C.K., Chern C.H., Wu M.F., et al. Expression of the triggering receptor expressed on myeloid cells-1 mRNA in a heterogeneous infected population. Int J Clin Pract 2009, 63(1):126-133.
22. Gibot S., Cravoisy A., Levy B., et al. Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia. N Engl J Med 2004, 350(5):451-458.
23. Richeldi L., Mariani M., Losi M., et al. Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections. Eur Respir J 2004, 24(2):247-250.
24. Huh J.W., Lim C.M., Koh Y., et al. Diagnostic utility of the soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid from patients with bilateral lung infiltrates. Crit Care 2008, 12(1):R6.
25. Determann R.M., Millo J.L., Gibot S., et al. Serial changes in soluble triggering receptor expressed on myeloid cells in the lung during development of ventilator-associated pneumonia. Intensive Care Med 2005, 31(11):1495-1500.
26. El Solh A.A., Akinnusi M.E., Peter M., et al. Triggering receptors expressed on myeloid cells in pulmonary aspiration syndromes. Intensive Care Med 2008, 34(6):1012-1019.
27. Phua J., Koay E.S., Zhang D., et al. Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections. Eur Respir J 2006, 28(4):695-702.
28. Muller B., Gencay M.M., Gibot S., et al. Circulating levels of soluble triggering receptor expressed on myeloid cells (sTREM)-1 in community-acquired pneumonia. Crit Care Med 2007, 35(3):990-991.
29. Chan M.C., Chang K.M., Chao W.C., et al. Evaluation of a new inflammatory molecule (triggering receptor expressed on myeloid cells-1) in the diagnosis of pleural effusion. Respirology 2007, 12(3):333-338.
30. Huang L.Y., Shi H.Z., Liang Q.L., et al. Expression of soluble triggering receptor expression on myeloid cells-1 in pleural effusion. Chin Med J (Engl) 2008, 121(17):1656-1661.
31. Bishara J., Goldberg E., Ashkenazi S., et al. Soluble triggering receptor expressed on myeloid cells-1 for diagnosing empyema. Ann Thorac Surg 2009, 87(1):251-254.
32. Determann R.M., Achouiti A.A., El Solh A.A., et al. Infectious pleural effusions can be identified by sTREM-1 levels. Respir Med 2010, 104(2):310-315.
33. Kim J.H., Park E.I., Kim W.H., et al. Soluble triggering receptor expressed on myeloid cells-1: role in diagnosis of pleural effusions. Tuberc Respir Dis 2007, 62:290-298.
34. Determann R.M., Weisfelt M., de Gans J., et al. Soluble triggering receptor expressed on myeloid cells 1: a biomarker for bacterial meningitis. Intensive Care Med 2006, 32(8):1243-1247.
35. Bishara J., Hadari N., Shalita-Chesner M., et al. Soluble triggering receptor expressed on myeloid cells-1 for distinguishing bacterial from aseptic meningitis in adults. Eur J Clin Microbiol Infect Dis 2007, 26(9):647-650.
36. Determann R.M., Schultz M.J., Geerlings S.E. Soluble triggering receptor expressed on myeloid cells-1 is not a sufficient biological marker for infection of the urinary tract. J Infect 2007, 54(6):e249-e250.
37. Determann R.M., van Till J.W., van Ruler O., et al. sTREM-1 is a potential useful biomarker for exclusion of ongoing infection in patients with secondary peritonitis. Cytokine 2009, 46(1):36-42.
38. Collins C.E., La D.T., Yang H.T., et al. Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis. Ann Rheum Dis 2009, 68(11):1768-1774.
39. Jiyong J., Tiancha H., Wei C., et al. Diagnostic value of the soluble triggering receptor expressed on myeloid cells-1 in bacterial infection: a meta-analysis. Intensive Care Med 2009, 35(4):587-595.
40. Yasuda T., Takeyama Y., Ueda T., et al. Increased levels of soluble triggering receptor expressed on myeloid cells-1 in patients with acute pancreatitis. Crit Care Med 2008, 36(7):2048-2053.
41. Ferat-Osorio E., Wong-Baeza I., Esquivel-Callejas N., et al. Triggering receptor expressed on myeloid cells-1 expression on monocytes is associated with inflammation but not with infection in acute pancreatitis. Crit Care 2009, 13(3):R69.
42. Wang D.Y., Qin R.Y., Liu Z.R., et al. Expression of TREM-1 mRNA in acute pancreatitis. World J Gastroenterol 2004, 10(18):2744-2746.
43. Adib-Conquy M., Monchi M., Goulenok C., et al. Increased plasma levels of soluble triggering receptor expressed on myeloid cells 1 and procalcitonin after cardiac surgery and cardiac arrest without infection. Shock 2007, 28(4):406-410.
44. Ferat-Osorio E., Esquivel-Callejas N., Wong-Baeza I., et al. The increased expression of TREM-1 on monocytes is associated with infectious and noninfectious inflammatory processes. J Surg Res 2008, 150(1):110-117.
45. Schenk M., Bouchon A., Seibold F., et al. TREM-1-expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases. J Clin Invest 2007, 117(10):3097-3106.
46. Tzivras M., Koussoulas V., Giamarellos-Bourboulis E.J., et al. Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease. World J Gastroenterol 2006, 12(21):3416-3419.
47. Park J.J., Cheon J.H., Kim B.Y., et al. Correlation of serum-soluble triggering receptor expressed on myeloid cells-1 with clinical disease activity in inflammatory bowel disease. Dig Dis Sci 2009, 54(7):1525-1531.
48. Koussoulas V., Tzivras M., Giamarellos-Bourboulis E.J., et al. Can soluble triggering receptor expressed on myeloid cells (sTREM-1) be considered an anti-inflammatory mediator in the pathogenesis of peptic ulcer disease?. Dig Dis Sci 2007, 52(9):2166-2169.
49. Radsak M.P., Taube C., Haselmayer P., et al. Soluble triggering receptor expressed on myeloid cells 1 is released in patients with stable chronic obstructive pulmonary disease. Clin Dev Immunol 2007, 2007:52040.
50. Ho C.C., Liao W.Y., Wang C.Y., et al. TREM-1 expression in tumor-associated macrophages and clinical outcome in lung cancer. Am J Respir Crit Care Med 2008, 177(7):763-770.
51. Daikeler T., Regenass S., Tyndall A., et al. Increased serum levels of soluble triggering receptor expressed on myeloid cells-1 in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Rheum Dis 2008, 67(5):723-724.
52. Hirayama K., Nagai M., Ebihara I., et al. Serum ratio of soluble triggering receptor expressed on myeloid cells-1 to creatinine is a useful marker of infectious complications in myeloperoxidase-antineutrophil cytoplasmic antibody-associated renal vasculitis. Nephrol Dial Transplant 2011, 26(3):868-874.
53. Gibot S., Cravoisy A., Kolopp-Sarda M.N., et al. Time-course of sTREM (soluble triggering receptor expressed on myeloid cells)-1, procalcitonin, and C-reactive protein plasma concentrations during sepsis. Crit Care Med 2005, 33(4):792-796.
54. Giamarellos-Bourboulis E.J., Zakynthinos S., Baziaka F., et al. Soluble triggering receptor expressed on myeloid cells 1 as an anti-inflammatory mediator in sepsis. Intensive Care Med 2006, 32(2):237-243.
55. Tejera A., Santolaria F., Diez M.L., et al. Prognosis of community acquired pneumonia (CAP): value of triggering receptor expressed on myeloid cells-1 (TREM-1) and other mediators of the inflammatory response. Cytokine 2007, 38(3):117-123.
56. Bopp C., Hofer S., Bouchon A., et al. Soluble TREM-1 is not suitable for distinguishing between systemic inflammatory response syndrome and sepsis survivors and nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol 2009, 26(6):504-507.
57. Gibot S., Buonsanti C., Massin F., et al. Modulation of the triggering receptor expressed on the myeloid cell type 1 pathway in murine septic shock. Infect Immun 2006, 74(5):2823-2830.
58. Gibot S., Alauzet C., Massin F., et al. Modulation of the triggering receptor expressed on myeloid cells-1 pathway during pneumonia in rats. J Infect Dis 2006, 194(7):975-983.
59. Wiersinga W.J., Veer C.T., Wieland C.W., et al. Expression profile and function of triggering receptor expressed on myeloid cells-1 during melioidosis. J Infect Dis 2007, 196(11):1707-1716.
60. Gibot S., Massin F., Alauzet C., et al. Effects of the TREM 1 pathway modulation during hemorrhagic shock in rats. Shock 2009, 32(6):633-637.
61. Gibot S., Massin F., Alauzet C., et al. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats. Crit Care Med 2008, 36(2):504-510.
62. Pamuk O.N., Lapchak P.H., Rani P., et al. Spleen tyrosine kinase inhibition prevents tissue damage after ischemia reperfusion injury. Am J Physiol Gastrointest Liver Physiol 2010, 299(2):G391-G399.
63. Kamei K., Yasuda T., Ueda T., et al. Role of triggering receptor expressed on myeloid cells-1 in experimental severe acute pancreatitis. J Hepatobiliary Pancreat Sci 2010, 17(3):305-312.
64. Murakami Y., Akahoshi T., Aoki N., et al. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. Arthritis Rheum 2009, 60(6):1615-1623.
65. Johansson M., Tan T., de Visser K.E., et al. Immune cells as anti-cancer therapeutic targets and tools. J Cell Biochem 2007, 101(4):918-926.
66. Horonenko G., Hoyt J.C., Robbins R.A., et al. Soluble triggering receptor expressed on myeloid cell-1 is increased in patients with ventilator-associated pneumonia: a preliminary report. Chest 2007, 132(1):58-63.
67. Anand N.J., Zuick S., Klesney-Tait J., et al. Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. Chest 2009, 135(3):641-647. 68.
68. Oudhuis G.J., Beuving J., Bergmans D., et al. Soluble triggering receptor expressed on myeloid cells-1 in bronchoalveolar lavage fluid is not predictive for ventilator-associated pneumonia. Intensive Care Med 2009, 35(7):1265-1270.